Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Retatrutide's in vitro cAMP potency is reported as roughly balanced across the three receptors with a bias toward GCGR and GIPR relative to GLP-1R
Diabetes Obes Metab 18(6):581589
Unlike other melanocortin peptides, KPV exhibits potent anti-inflammatory effects independent of melanocortin receptors
Retatrutide versus other weight loss peptides Compared to semaglutide: Semaglutide targets only GLP-1 receptors, achieving approximately 15-17% weight loss in clinical trials
Left, map with the GLP-1R ECD masked
This immediate feedback helps you understand your status right away, without needing to interpret complicated charts
US$ 23.55
US$ 23.19
US$ 21.83
US$ 24.01
US$ 28.04
US$ 28.20
